A House Republican connected the controversial generic labeling rule to anger over drug pricing, potentially landing another blow against FDA implementation of the regulation.
FDA Feels Heat On Drug Pricing And Generic Labeling Rule
House subcommittee chair suggests agency taking contradictory positions by worrying about pricing while proposing reg that could increase drug costs.